Piritrexim isethionate is a lipid-soluble inhibitor of dihydrofolate reductase (DHFR) that appears to be an active agent in patients with metastatic urothelial cancer when administered as a 5-day, low-dose oral schedule.
Molecular Weight:
451.49
CAS Number:
[79483-69-5]
Formula:
C19H25N5O6S
Target:
DHFR|||Others
T68684
* VAT and and shipping costs not included. Errors and price changes excepted